Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-18

Clinical Trial Update: Donepezil Versus Non-drug Treatment in Alzheimer's Disease. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating donepezil versus non-drug treatment for early-onset Alzheimer's disease. The study status is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Donepezil (donepezil)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Alzheimer Disease, Early Onset | Phase 3 | Status: RECRUITING